42 CFR 423, Subpart V - Part D Marketing Requirements
- § 423.2260 — Definitions concerning marketing materials.
- § 423.2262 — Review and distribution of marketing materials.
- § 423.2264 — Guidelines for CMS review.
- § 423.2266 — Deemed approval.
- § 423.2268 — Standards for Part D marketing.
- § 423.2272 — Licensing of marketing representatives and confirmation of marketing resources.
- § 423.2274 — Broker and agent requirements.
- § 423.2276 — Employer group retiree marketing.
Title 42 published on 2012-10-01
The following are only the Rules published in the Federal Register after the published date of Title 42.
For a complete list of all Rules, Proposed Rules, and Notices view the Rulemaking tab.
Title 42 published on 2012-10-01
The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 42 CFR 423 after this date.
GPO FDSys XML | Text type regulations.gov FR Doc. 2013-03921 RIN 0938-AR69 CMS-4173-P DEPARTMENT OF HEALTH AND HUMAN SERVICES, Centers for Medicare & Medicaid Services Proposed rule. To be assured consideration, comments must be received at one of the addresses provided below, no later than 5 p.m. EST on April 16, 2013. 42 CFR Parts 422 and 423 This proposed rule would implement medical loss ratio (MLR) requirements for the Medicare Advantage Program and the Medicare Prescription Drug Benefit Program under the Patient Protection and Affordable Care Act.
GPO FDSys XML | Text type regulations.gov FR Doc. 2012-26900 RIN 0938-AR11 CMS-1590-FC DEPARTMENT OF HEALTH AND HUMAN SERVICES, Centers for Medicare & Medicaid Services Final rule with comment period. Effective date: The provisions of this final rule with comment period are effective on January 1, 2013 with the exception of provisions in § 410.38 which are effective on July 1, 2013. The incorporation by reference of certain publications listed in the rule was approved by the Director of the Federal Register on May 16, 2012. Comment date: To be assured consideration, comments must be received at one of the addresses provided below, no later than 5 p.m. on December 31, 2012. (See the SUPPLEMENTARY INFORMATION section of this final rule with comment period for a list of the provisions open for comment.) 42 CFR Parts 410, 414, 415, 421, 423, 425, 486, and 495 This major final rule with comment period addresses changes to the physician fee schedule, payments for Part B drugs, and other Medicare Part B payment policies to ensure that our payment systems are updated to reflect changes in medical practice and the relative value of services. It also implements provisions of the Affordable Care Act by establishing a face-to-face encounter as a condition of payment for certain durable medical equipment (DME) items. In addition, it implements statutory changes regarding the termination of non-random prepayment review. This final rule with comment period also includes a discussion in the Supplementary Information regarding various programs . (See the Table of Contents for a listing of the specific issues addressed in this final rule with comment period.)